Lamellar Biomedical, a biotechnology company developing a range of patent-protected medical devices and pharmaceuticals, based on Lamellasome™ technology, is pleased to announce the publication of a paper in the Supportive Care in Cancer Journal.

Follow this link:
Positive pre-clinical study data of Lamellar Biomedical’s Visco-ease published in Supportive Care Journal

Scroll to Top